A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG study1
- Citation:
- Am J Clin Oncol vol 31 (6) 573-579
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 644
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- M01 RR000585, U10 CA052352, U10 CA037417, CA-37404, M01 RR000585-332026, U10 CA060276, CA-52352, CA-35195, M01 RR000585-332075, U10 CA037404, U10 CA035195, CA-35103, CA-25224, CA-60276, U10 CA035101, U10 CA035415, U10 CA063849, CA-35415, CA-37417, CA-35101, U10 CA025224, CA-63849, U10 CA035103
- Corr. Author:
- Authors:
- Svetomir N. Markovic Vera J. Suman Wendy K. Nevala Louis Geeraerts Edward T. Creagan Lori A. Erickson Kendrith M. Rowland Roscoe F. Morton William L. Horvath Mark R. Pittelkow
- Networks:
- Study
- NCCTG-N0071
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords:
- GM-CSF, melanoma, aerosol, immunotherapy